Healthpeak Properties Inc. Common Stock vs ImmunityBio Inc. Common Stock — how do they compare? Healthpeak Properties Inc. Common Stock trades at $18.74 (market cap $12.77B), while ImmunityBio Inc. Common Stock trades at $10.52 (market cap $10.51B). The key difference: Healthpeak Properties Inc. Common Stock is the larger of the two by market cap, and Healthpeak Properties Inc. Common Stock pays a 6.59% dividend while ImmunityBio Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Healthpeak Properties Inc. Common Stock for 0 Days and ImmunityBio Inc. Common Stock for 0 Days on average.
| DOC | IBRX | |
|---|---|---|
Market Cap | $12.77B | $10.51B |
Volume | 11,021,809 | 10,445,785 |
Sector | Real Estate | Health |
52-Week High | $22.82 | $11.55 |
52-Week Low | $15.78 | $1.98 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $21.46B | $10.97B |
Dividend Yield | 6.59% | — |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Healthpeak Properties is a healthcare real estate investment trust in the United States. It owns, operates, and develops outpatient medical, laboratory, and senior housing properties.
Read more on DOC →ImmunityBio develops immune-based therapies for cancer and infectious diseases. Its programs are designed to activate and strengthen the body’s immune response.
Read more on IBRX →